BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 22664371)

  • 1. Comparison of long-term outcomes in STEMI and NSTE-ACS after coronary stent placement: an analysis in a real world BMS and DES population.
    van Leeuwen MA; Daemen J; van Mieghem NM; de Boer SP; Boersma E; van Geuns RJ; Zijlstra F; van Domburg RT; Serruys PW;
    Int J Cardiol; 2013 Sep; 167(5):2082-7. PubMed ID: 22664371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS.
    Généreux P; Madhavan MV; Mintz GS; Maehara A; Palmerini T; Lasalle L; Xu K; McAndrew T; Kirtane A; Lansky AJ; Brener SJ; Mehran R; Stone GW
    J Am Coll Cardiol; 2014 May; 63(18):1845-54. PubMed ID: 24561145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
    Holmvang L; Kelbæk H; Kaltoft A; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
    JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR.
    Sarno G; Lagerqvist B; Nilsson J; Frobert O; Hambraeus K; Varenhorst C; Jensen UJ; Tödt T; Götberg M; James SK
    J Am Coll Cardiol; 2014 Jul; 64(1):16-24. PubMed ID: 24998123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
    Wang CH; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Yang M
    Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with titanium-nitride-oxide-coated versus everolimus-eluting stents: insights from the BASE-ACS trial.
    Romppanen H; Nammas W; Kervinen K; Mikkelsson J; Pietilä M; Lalmand J; Rivero-Crespo F; Pentikäinen M; Tedjokusumo P; Karjalainen PP
    Minerva Cardioangiol; 2013 Apr; 61(2):201-9. PubMed ID: 23492603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
    Simsek C; Magro M; Boersma E; Onuma Y; Nauta S; Daemen J; Gaspersz M; van Geuns RJ; van der Giessen W; van Domburg R; Serruys P
    J Invasive Cardiol; 2011 Aug; 23(8):336-41. PubMed ID: 21828397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome after drug eluting stenting in patients with ST-segment elevation myocardial infarction: data from the REAL registry.
    Campo G; Saia F; Percoco G; Manari A; Santarelli A; Vignali L; Varani E; Benassi A; Sangiorgio P; Tarantino F; Magnavacchi P; De Palma R; Guastaroba P; Marzocchi A
    Int J Cardiol; 2010 Apr; 140(2):154-60. PubMed ID: 19056134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of drug-eluting stents to bare-metal stents in ST-elevation myocardial infarction in long-term follow-up.
    Kübler P; Jankowska EA; Ferenc M; Ponikowski P; Banasiak W; Reczuch K
    Kardiol Pol; 2013; 71(1):25-31. PubMed ID: 23348530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous coronary intervention for acute coronary syndrome due to graft failure: use of bare-metal and drug-eluting stents and subsequent long-term clinical outcome.
    Harskamp RE; Kuijt WJ; Damman P; Beijk MA; Grundeken MJ; Woudstra P; Tijssen JG; de Winter RJ
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):203-9. PubMed ID: 22508617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of patients receiving zotarolimus-eluting stents in ST elevation myocardial infarction, non-ST elevation acute coronary syndrome, and stable angina: data from the Resolute program.
    Widimsky P; Motovska Z; Belardi J; Serruys P; Silber S; Windecker S; Neumann FJ
    Int J Cardiol; 2013 Oct; 168(4):3522-6. PubMed ID: 23706326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction.
    Jensen LO; Maeng M; Thayssen P; Kaltoft A; Tilsted HH; Bøttcher M; Lassen JF; Hansen KN; Krusell LR; Rasmussen K; Pedersen KE; Pedersen L; Paaske Johnsen S; Sørensen HT; Thuesen L
    Circ Cardiovasc Interv; 2008 Dec; 1(3):176-84. PubMed ID: 20031676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Borderline trend towards long-term mortality benefit from drug eluting stents implantation in ST-elevation myocardial infarction patients in Poland-data from NRDES registry.
    Siudak Z; Dziewierz A; Rakowski T; Żmudka K; Legutko J; Bartuś S; Dragan J; Zasada W; Tokarek T; Kułaga T; Partyka Ł; Dudek D
    Catheter Cardiovasc Interv; 2014 Feb; 83(3):436-42. PubMed ID: 24038740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target lesion revascularization after bare-metal or drug-eluting stents: clinical presentations and outcomes.
    Hayes KR; Applegate RJ; Sacrinty MT; Kutcher MA; Gandhi SK; Santos RM; Little WC
    J Invasive Cardiol; 2010 Jun; 22(6):266-70. PubMed ID: 20516505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel-eluting versus bare-metal stents in acute ST elevation myocardial infarction (STEMI).
    Hamirani YS; Jibrin I; Abraham D; Merriman B; Wenz C; Bahr RD
    Crit Pathw Cardiol; 2008 Dec; 7(4):232-8. PubMed ID: 19050419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis.
    Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Valgimigli M; Frati G; Kedhi E; Smits PC; Kaiser C; Genereux P; Galatius S; Kirtane AJ; Stone GW
    J Am Coll Cardiol; 2013 Aug; 62(6):496-504. PubMed ID: 23747778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prima-vista multi-vessel percutaneous coronary intervention in haemodynamically stable patients with acute coronary syndromes: analysis of over 4.400 patients in the EHS-PCI registry.
    Bauer T; Zeymer U; Hochadel M; Möllmann H; Weidinger F; Zahn R; Nef HM; Hamm CW; Marco J; Gitt AK
    Int J Cardiol; 2013 Jul; 166(3):596-600. PubMed ID: 22192297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of late (3-year) registry data outcomes using bare metal versus drug-eluting stents for treating ST-segment elevation acute myocardial infarctions.
    Assali A; Vaduganathan M; Vaknin-Assa H; Lev EI; Brosh D; Teplitsky I; Bental T; Battler A; Kornowski R
    Am J Cardiol; 2012 Jun; 109(11):1563-8. PubMed ID: 22440117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year outcomes of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with biodegradable polymer-coated sirolimus-eluting stents: Insights from the CREATE trial.
    Liu HL; Jin ZG; Yang SL; Han W; Jing QM; Zhang L; Luo JP; Ma DX; Liu Y; Yang LX; Jiang TM; Qu P; Li WM; Li SM; Xu B; Gao RL; Han YL
    J Cardiol; 2017 Jan; 69(1):149-155. PubMed ID: 26972344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting stents and bare metal stents in patients with NSTE-ACS: 2-year outcome from the randomised BASKET-PROVE trial.
    Pedersen SH; Pfisterer M; Kaiser C; Jensen JS; Alber H; Rickenbacher P; Sørensen R; Iversen A; Jensen MT; Wadt K; Galatius S;
    EuroIntervention; 2014 May; 10(1):58-64. PubMed ID: 24694667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.